Implementation of the Drug Supply Chain Security Act (DSCSA) continues to transform the pharmaceutical supply chain. As the industry works toward the law’s 2023 finish line, HDA’s annual Traceability Seminar will bring together healthcare supply chain leaders to learn more about upcoming DSCSA implementation milestones as well as innovative approaches and lessons learned as distributors, manufacturers and dispensers implement serialization and traceability technologies to further preserve the safety and security of the healthcare supply chain.

Join HDA, fellow supply chain colleagues, federal and state regulators and others to hear from industry traceability experts, who will provide details on the timelines for implementation, updates on industry pilot projects to support saleable returns requirements in 2019, 3PL perspectives, strategies for unit-level serialization and the challenges that need to be overcome as well as the key regulatory perspectives on the entire process. Additionally, meet with key service and technology providers, who will present their innovative products and services during networking functions.